Sichuan Cancer Hospital

Sichuan Cancer Hospital is the largest and highest-ranked cancer specialty hospital in Western China, serving as the electronic science and technology university's affiliated cancer hospital and the headquarters of Sichuan Province's cancer prevention and treatment network. Founded in 1979, this Grade A tertiary hospital has grown into the definitive destination for oncology care across China's vast western regions, combining comprehensive cancer services with a research mandate that spans the entire province.

History and Scale: Originally established as Sichuan Second People's Hospital, the institution evolved over four decades into a dedicated cancer center operating across two campuses — Wuhou (the original, 114 mu / 7.6 hectares) and Tianfu (the new campus, opened December 2023, 135 mu / 9 hectares). Combined, the two campuses hold 2,800 planned beds with 1,500 currently open at Wuhou. In 2025, the hospital recorded over 1.02 million outpatient visits, 98,000 inpatient admissions, and 23,000 surgical procedures, with an average length of stay of just 5.8 days — a remarkable efficiency metric for a major cancer center.

Star Specialties: The hospital holds four National Key Clinical Specialties: Medical Oncology, Radiation Oncology, Head & Neck Oncology, and General Surgery. Its Radiation Oncology Department is the crown jewel — home to Southwest China's first proton therapy system, the region's first MRI-guided linear accelerator, CyberKnife, and TomoTherapy, making it one of the most technologically complete radiotherapy centers in Asia. Treatment outcomes for cervical cancer, esophageal cancer, and nasopharyngeal carcinoma reach international benchmark levels. The Medical Oncology Department was among the first in China to deploy CAR-T cell therapy at scale, with internationally recognized expertise in lymphoma and nasopharyngeal cancer. The surgical oncology program operates a fourth-generation da Vinci robotic system and pioneered minimally invasive approaches now adopted across Southwest China.

Achievements and Recognition: In national tertiary hospital performance evaluations, Sichuan Cancer Hospital ranks 4th among all cancer specialty hospitals nationwide (Grade A), with a CMI (Case Mix Index) value that has ranked 3rd nationally among cancer hospitals for six consecutive years — indicating exceptional case complexity. On the Fudan Hospital Rankings, it has held the #1 position for oncology in Southwest China for ten straight years and ranks 9th nationally in oncology reputation. Its STEM (Science and Technology Evaluation Metrics) ranking for oncology stands at 8th among specialty hospitals nationally.

International Services: While the hospital does not operate a branded international medical center like some Beijing or Shanghai peers, its International Medical Service Desk at the Wuhou campus provides English-speaking patient coordinators, expedited appointment scheduling, and assistance with international insurance direct billing. The Tianfu campus, with its newer facilities, is being positioned to serve cross-border patients from Southeast Asia and Belt and Road countries. Interpreter services can be arranged with advance notice through the hospital's international liaison office.

Why Choose Sichuan Cancer Hospital: For international patients requiring advanced radiotherapy — particularly proton therapy, stereotactic radiosurgery, or MRI-guided adaptive radiation — this hospital offers Asia's most complete technology arsenal at a fraction of Western costs. Its combination of high CMI (genuinely complex cases), top-10 national ranking, and Chengdu's lower cost of living compared to coastal cities makes it a compelling choice for cancer patients seeking world-class treatment without the premium pricing of Beijing or Shanghai.